文献速递糖尿病

轴突肿胀与2型糖尿病相关,但与远端糖尿病感觉运动多发性神经病变无关

Axonal swellings are related to type 2 diabetes, but not to distal diabetic sensorimotor polyneuropathy.
PubMed 文献 · Diabetologia · 2021-01-23

研究纳入249名参与者,比较健康对照、无远端糖尿病感觉运动多发性神经病变(DSP)的2型糖尿病患者、无痛性DSP+和疼痛性DSP+患者的轴突肿胀比。发现在IENFD>1.0纤维/mm的参与者中,2型糖尿病患者的轴突肿胀比健康对照更高(p<0.001),但DSP-与无痛性DSP+之间、无痛性与疼痛性DSP+之间无差异。轴突肿胀比与HbA1c弱相关(r=0.16,p=0.04),与DSP严重程度、BMI或糖尿病病程无关。

要点

  • 在IENFD>1.0纤维/mm时,2型糖尿病患者的轴突肿胀比健康对照更高。
  • 轴突肿胀比在DSP-与无痛性DSP+之间、无痛性与疼痛性DSP+之间无差异。
  • 轴突肿胀比与HbA1c弱相关,与DSP严重程度、BMI或糖尿病病程无关。

核心结论

  • 在IENFD>1.0纤维/mm的2型糖尿病患者中,轴突肿胀比与2型糖尿病相关,但与DSP或疼痛性DSP无关。
  • 轴突肿胀可能是2型糖尿病感觉神经损伤的早期标志物。

研究设计与样本

  • 研究纳入249名参与者,来自Pain in Neuropathy Study(英国)和International Diabetic Neuropathy Consortium(丹麦)。
  • 参与者接受结构化神经学检查、神经传导研究、定量感觉测试和皮肤活检。
  • 分组包括健康对照(n=45)、无DSP的2型糖尿病(DSP-;n=31)、有DSP证据(DSP+;n=173),后者再分为无痛性DSP+(n=74)和疼痛性DSP+(n=99)。
  • 轴突肿胀定义为表皮穿透纤维上直径超过1.5μm的增大;轴突肿胀比=轴突肿胀数/表皮内神经纤维数。

主要发现

  • IENFD中位数(IQR)为:健康对照6.7(5.2-9.2)纤维/mm;DSP- 6.2(4.4-7.3)纤维/mm;无痛性DSP+ 1.3(0.5-2.2)纤维/mm;疼痛性DSP+ 0.84(0.4-1.6)纤维/mm。
  • 在IENFD>1.0纤维/mm的参与者中,2型糖尿病患者的轴突肿胀比健康对照更高(p<0.001)。
  • DSP-与无痛性DSP+之间、无痛性DSP+与疼痛性DSP+之间的轴突肿胀比无差异。
  • 轴突肿胀比与HbA1c弱相关(r=0.16,p=0.04),与Toronto Clinical Scoring System、BMI或2型糖尿病病程无相关。

临床怎么用

  • 在IENFD保留(>1.0纤维/mm)的2型糖尿病患者中,轴突肿胀比可能提示早期感觉神经损伤。
  • 轴突肿胀比不宜用于区分DSP是否存在或是否伴疼痛。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Distal diabetic sensorimotor polyneuropathy (DSP) is a common complication of diabetes with many patients showing a reduction of intraepidermal nerve fibre density (IENFD) from skin biopsy, a validated and sensitive diagnostic tool for the assessment of DSP. Axonal swelling ratio is a morphological quantification altered in DSP. It is, however, unclear if axonal swellings are related to diabetes or DSP. The aim of this study was to investigate how axonal swellings in cutaneous nerve fibres are related to type 2 diabetes mellitus, DSP and neuropathic pain in a well-defined cohort of patients diagnosed with type 2 diabetes. METHODS: A total of 249 participants, from the Pain in Neuropathy Study (UK) and the International Diabetic Neuropathy Consortium (Denmark), underwent a structured neurological examination, nerve conduction studies, quantitative sensory testing and skin biopsy. The study included four groups: healthy control study participants without diabetes (n = 45); participants with type 2 diabetes without DSP (DSP-; n = 31); and participants with evidence of DSP (DSP+; n = 173); the last were further separated into painless DSP+ (n = 74) and painful DSP+ (n = 99). Axonal swellings were defined as enlargements on epidermal-penetrating fibres exceeding 1.5 μm in diameter. Axonal swelling ratio is calculated by dividing the number of axonal swellings by the number of intraepidermal nerve fibres. RESULTS: Median (IQR) IENFD (fibres/mm) was: 6.7 (5.2-9.2) for healthy control participants; 6.2 (4.4-7.3) for DSP-; 1.3 (0.5-2.2) for painless DSP+; and 0.84 (0.4-1.6) for painful DSP+. Swelling ratios were calculated for all participants and those with IENFD > 1.0 fibre/mm. When only those participants with IENFD > 1.0 fibre/mm were included, the axonal swelling ratio was higher in participants with type 2 diabetes when compared with healthy control participants (p < 0.001); however, there was no difference between DSP- and painless DSP+ participants, or between painless DSP+ and painful DSP+ participants. The axonal swelling ratio correlated weakly with HbA1c (r = 0.16, p = 0.04), but did not correlate with the Toronto Clinical Scoring System (surrogate measure of DSP severity), BMI or type 2 diabetes duration. CONCLUSIONS/INTERPRETATION: In individuals with type 2 diabetes where IENFD is >1.0 fibre/mm, axonal swelling ratio is related to type 2 diabetes but is not related to DSP or painful DSP. Axonal swellings may be an early marker of sensory nerve injury in type 2 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Karlsson P, Gylfadottir SS, Kristensen AG, et al. Axonal swellings are related to type 2 diabetes, but not to distal diabetic sensorimotor polyneuropathy. Diabetologia. 2021. PMID: 33483760. doi:10.1007/s00125-020-05352-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。